Structural basis of new allosteric inhibition in kinesin spindle protein eg5

ACS Chemical Biology

Volumn 10, Issue 4, 2015, Pages 1128-1136

  Yokoyama, Hideshi ^a   Sawada, Jun Ichi ^a   Katoh, Shiori ^a   Matsuno, Kenji ^a   Ogo, Naohisa ^a   Ishikawa, Yoshinobu ^a   Hashimoto, Hiroshi ^a   Fujii, Satoshi ^a   Asai, Akira ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; KINESIN SPINDLE PROTEIN EG5; PROTEIN; PROTEIN INHIBITOR; PVZB 1194; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATE; BIPHENYL DERIVATIVE; KIF11 PROTEIN, HUMAN; KINESIN; PVZB1194; SULFONAMIDE; TYROSINE;

ALLOSTERISM; ARTICLE; ATPASE ACTIVITY ASSAY; BINDING SITE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; CRYSTALLIZATION; DELETION MUTANT; DRUG PROTEIN BINDING; DRUG STRUCTURE; HYDROGEN BOND; MICHAELIS CONSTANT; MICROTUBULE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN STRUCTURE; THERMOSTABILITY; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; METABOLISM; PROTEIN TERTIARY STRUCTURE; X RAY CRYSTALLOGRAPHY;

ADENOSINE TRIPHOSPHATE; BINDING SITES; BIPHENYL COMPOUNDS; CRYSTALLOGRAPHY, X-RAY; HUMANS; HYDROGEN BONDING; KINESIN; MICROTUBULES; MODELS, MOLECULAR; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; SULFONAMIDES; TYROSINE;

EID: 84928170352     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb500939x     Document Type: Article

References (37)

1. Miki, H., Okada, Y., and Hirokawa, N. (2005) Analysis of the kinesin superfamily: insights into structure and function Trends Cell Biol. 15, 467-476
2. Blangy, A., Lane, H. A., d¢Hérin, P., Harper, M., Kress, M., and Nigg, E. A. (1995) Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo Cell 83, 1159-1169
3. Tao, W., South, V. J., Zhang, Y., Davide, J. P., Farrell, L., Kohl, N. E., Sepp-Lorenzino, L., and Lobell, R. B. (2005) Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage Cancer Cell 8, 49-59
4. Marcus, A. I., Peters, U., Thomas, S. L., Garrett, S., Zelnak, A., Kapoor, T. M., and Giannakakou, P. (2005) Mitotic kinesin inhibitors induce mitotic arrest and cell death in taxol-resistant and -sensitive cancer cells J. Biol. Chem. 280, 11569-11577
5. Sakowicz, R., Finer, J. T., Beraud, C., Crompton, A., Lewis, E., Fritsch, A., Lee, Y., Mak, J., Moody, R., Turincio, R., Chabala, J. C., Gonzales, P., Roth, S., Weitman, S., and Wood, K. W. (2004) Antitumor activity of a kinesin inhibitor Cancer Res. 64, 3276-3280
6. Mayer, T. U., Kapoor, T. M., Haggarty, S. J., King, R. W., Schreiber, S. L., and Mitchison, T. J. (1999) Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen Science 286, 971-974
7. DeBonis, S., Skoufias, D. A., Lebeau, L., Lopez, R., Robin, G., Margolis, R. L., Wade, R. H., and Kozielski, F. (2004) In vitro screening for inhibitors of the human mitotic kinesin Eg5 with antimitotic and antitumor activities Mol. Cancer Ther. 3, 1079-1090
8. DeBonis, S., Skoufias, D. A., Indorato, R. L., Liger, F., Marquet, B., Laggner, C., Joseph, B., and Kozielski, F. (2008) Structure-activity relationship of S -trityl- l -cysteine analogues as inhibitors of the human mitotic kinesin Eg5 J. Med. Chem. 51, 1115-1125
9. Skoufias, D. A., DeBonis, S., Saoudi, Y., Lebeau, L., Crevel, I., Cross, R., Wade, R. H., Hackney, D., and Kozielski, F. (2006) S -Trityl- l -cysteine is a reversible, tight binding inhibitor of the human kinesin Eg5 that specifically blocks mitotic progression J. Biol. Chem. 281, 17559-17569
10. Ogo, N., Oishi, S., Matsuno, K., Sawada, J., Fujii, N., and Asai, A. (2007) Synthesis and biological evaluation of l -cysteine derivatives as mitotic kinesin Eg5 inhibitors Bioorg. Med. Chem. Lett. 17, 3921-3924
11. El-Nassan, H. B. (2013) Advances in the discovery of kinesin spindle protein (Eg5) inhibitors as antitumor agents Eur. J. Med. Chem. 62, 614-631
12. Yan, Y., Sardana, V., Xu, B., Homnick, C., Halczenko, W., Buser, C. A., Schaber, M., Hartman, G. D., Huber, H. E., and Kuo, L. C. (2004) Inhibition of a mitotic protein: where, how, and conformational consequences J. Mol. Biol. 335, 547-554
13. Kaan, H. Y. K., Ulaganathan, V., Hackney, D. D., and Kozielski, F. (2010) An allosteric transition trapped in an intermediate state of a new kinesin-inhibitor complex Biochem. J. 425, 55-60
14. Zhang, B., Liu, J. F., Xu, Y., and Ng, S. C. (2008) Crystal structure of Hs Eg5 in complex with clinical candidate CK0238273 provides insight into inhibitory mechanism, potency, and specificity Biochem. Biophys. Res. Commun. 372, 565-570
15. Talapatra, S. K., Schuttelkopf, A. W., and Kozielski, F. (2012) The structure of the ternary Eg5-ADP-ispinesib complex Acta Crystallogr. D Biol. Crystallogr. 68, 1311-1319
16. Maliga, Z., Kapoor, T. M., and Mitchison, T. J. (2002) Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5 Chem. Biol. 9, 989-996
17. Lad, L., Luo, L., Carson, J. D., Wood, K. W., Hartman, J. J., Copeland, R. A., and Sakowicz, R. (2008) Mechanism of inhibition of human KSP by ispinesib Biochemistry 47, 3576-3585
18. Luo, L., Parrish, C. A., Nevins, N., McNulty, D. E., Chaudhari, A. M., Carson, J. D., Sudakin, V., Shaw, A. N., Lehr, R., Zhao, H., Sweitzer, S., Lad, L., Wood, K. W., Sakowicz, R., Annan, R. S., Huang, P. S., Jackson, J. R., Dhanak, D., Copeland, R. A., and Auger, K. R. (2007) ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism Nat. Chem. Biol. 3, 722-726
19. Matsuno, K., Sawada, J., Sugimoto, M., Ogo, N., and Asai, A. (2009) Bis(hetero)aryl derivatives as unique kinesin spindle protein inhibitors Bioorg. Med. Chem. Lett. 19, 1058-1061
20. Parrish, C. A., Adams, N. D., Auger, K. R., Burgess, J. L., Carson, J. D., Chaudhari, A. M., Copeland, R. A., Diamond, M. A., Donatelli, C. A., Duffy, K. J., Faucette, L. F., Finer, J. T., Huffman, W. F., Hugger, E. D., Jackson, J. R., Knight, S. D., Luo, L., Moore, M. L., Newlander, K. A., Ridgers, L. H., Sakowicz, R., Shaw, A. N., Sung, C.-M. M., Sutton, D., Wood, K. W., Zhang, S.-Y., Zimmerman, M. N., and Dhanak, D. (2007) Novel ATP-competitive kinesin spindle protein inhibitors J. Med. Chem. 50, 4939-4952
21. Knight, S. D. and Parrish, C. A. (2008) Recent progress in the identification and clinical evaluation of inhibitors of the mitotic kinesin KSP Curr. Top. Med. Chem. 8, 888-904
22. Ulaganathan, V., Talapatra, S. K., Rath, O., Pannifer, A., Hackney, D. D., and Kozielski, F. (2013) Structural insights into a unique inhibitor binding pocket in kinesin spindle protein J. Am. Chem. Soc. 135, 2263-2272
23. Shimizu, M., Ishii, H., Ogo, N., Matsuno, K., and Asai, A. (2010) Biochemical analysis of cellular target of S -trityl- l -cysteine derivatives using affinity matrix Bioorg. Med. Chem. Lett. 20, 1578-1580
24. Niesen, F. H., Berglund, H., and Vedadi, M. (2007) The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability Nat. Protoc. 2, 2212-2221
25. Krissinel, E. and Henrick, K. (2004) Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions Acta Crystallogr. D Biol. Crystallogr. 60, 2256-2268
26. Turner, J., Anderson, R., Guo, J., Beraud, C., Fletterick, R., and Sakowicz, R. (2001) Crystal structure of the mitotic spindle kinesin Eg5 reveals a novel conformation of the neck-linker J. Biol. Chem. 276, 25496-25502
27. Parke, C. L., Wojcik, E. J., Kim, S., and Worthylake, D. K. (2010) ATP hydrolysis in Eg5 kinesin involves a catalytic two-water mechanism J. Biol. Chem. 285, 5859-5867
28. Sheth, P. R., Shipps, G. W., Jr., Seghezzi, W., Smith, C. K., Chuang, C.-C., Sanden, D., Basso, A. D., Vilenchik, L., Gray, K., Annis, D. A., Nickbarg, E., Ma, Y., Lahue, B., Herbst, R., and Le, H. V. (2010) Novel benzimidazole inhibitors bind to a unique site in the kinesin spindle protein motor domain Biochemistry 49, 8350-8358
29. Nitta, R., Okada, Y., and Hirokawa, N. (2008) Structural model for strain-dependent microtubule activation of Mg-ADP release from kinesin Nat. Struct. Mol. Biol. 15, 1067-1075
30. Otwinowski, Z. and Minor, W. (1997) Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol. 276, 307-326
31. Vagin, A. and Teplyakov, A. (2010) Molecular replacement with MOLREP Acta Crystallogr. D Biol. Crystallogr. 66, 22-25
32. Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., McNicholas, S. J., Murshudov, G. N., Pannu, N. S., Potterton, E. A., Powell, H. R., Read, R. J., Vagin, A., and Wilson, K. S. (2011) Overview of the CCP4 suite and current developments Acta Crystallogr. D Biol. Crystallogr. 67, 235-242
33. Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F., and Vagin, A. A. (2011) REFMAC5 for the refinement of macromolecular crystal structures Acta Crystallogr. D Biol. Crystallogr. 67, 355-367
34. Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Crystallography & NMR System: a new software suite for macromolecular structure determination Acta Crystallogr. D Biol. Crystallogr. 54, 905-921
35. Emsley, P. and Cowtan, K. (2004) Coot: model-building tools for molecular graphics Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132
36. Chou, T. C. (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies Pharm. Rev. 58, 621-681
37. Lovell, S. C., Davis, I. W., Arendall, W. B., III, de Bakker, P. I. W., Word, J. M., Prisant, M. G., Richardson, J. S., and Richardson, D. C. (2003) Structure validation by Cα geometry: and C deviation Proteins: Struct. Funct. Genet. 50, 437-450